Actinic Keratosis Market: Industry Analysis, Epidemiology, Pipeline Therapies, Treatment and Companies by DelveInsight| Sandoz Pharmaceuticals, Bausch Health Companies, LEO Pharma, Almirall S.A., Aqua Pharmaceuticals and Others.
Actinic keratosis is a chronic and prevalent disease affecting areas of sun-exposed skin where visible and subclinical, non-visible lesions coexist. This area of sun-damaged skin is prone to the development of further visible Actinic Keratosis lesions and sun-related skin cancer and is known as ‘field cancerization’. Actinic Keratosis lesions are being represented as small scaly patches that can be flat or slightly raised. Their color can range from one's skin tone to a reddish-brown color. They differ in size from 3 mm to 10 mm across, and they may gradually enlarge. Actinic Keratosis lesions appear on areas which are most commonly exposed to sun, such as the face, scalp, shoulders, neck, the back of the hands and forearms, etc.
DelveInsight's "Actinic
Keratosis Market Insights, Epidemiology, and Market
Forecast-2030" report delivers an in-depth understanding of the
Actinic Keratosis , historical and forecasted epidemiology as well as the
Actinic Keratosis market trends in the United States, EU5 (Germany, Spain,
Italy, France, and United Kingdom) and Japan.
Some key facts of Actinic
Keratosis Report are:
·
Actinic Keratosis is more prevalent among male
than female population. DelveInsight estimates that the male-to-female ratios
of Actinic Keratosis patients differ among various countries, but a male excess
is a consistent finding among all countries except Italy.
·
As per the estimation by DelveInsight’s
analysts, the United States had the highest prevalence of Actinic Keratosis
with approximately 66 million prevalent population in 2020.
·
Among the EU5 countries, Germany had the highest
prevalent population with approximately 8 million cases followed by the United
Kingdom with prevalent population of approximately 5 million in 2020. On the
other hand, Japan has the lowest prevalent population with approximately 7 lakh
Actinic keratosis cases in 2020.
·
Our analysis also suggests that due to the high
prevalence of Actinic Keratosis and potential for lesions to become cancerous,
maximum patients are treated.
View Report: https://www.delveinsight.com/report-store/actinic-keratosis-market
Request for Free
Sample Report: https://www.delveinsight.com/sample-request/actinic-keratosis-market
Actinic keratosis vary in appearance. Signs and symptoms
include:
·
Rough, dry or scaly patch of skin, usually less
than 1 inch (2.5 centimeters) in diameter
·
Flat to slightly raised patch or bump on the top
layer of skin
·
In some cases, a hard, wartlike surface
·
Color variations, including pink, red or brown
·
Itching, burning, bleeding or crusting
·
New patches or bumps on sun-exposed areas of the
head, neck, hands and forearms
Some of Actinic
Keratosis Companies
are:
·
Sandoz Pharmaceuticals
·
Bausch Health Companies (Formerly known as
Valeant Pharmaceuticals)
·
LEO Pharma
·
Almirall S.A.
·
Aqua Pharmaceuticals
·
Biofrontera
·
Galderma
·
DUSA Pharmaceuticals
·
Photonamic GmbH & Co. KG
·
Almirall/Athenex
·
And Many Others
View Report: https://www.delveinsight.com/report-store/actinic-keratosis-market
Request for Free
Sample Report: https://www.delveinsight.com/sample-request/actinic-keratosis-market
Actinic
Keratosis therapies are:
·
Aldara
·
Zyclara
·
Solaraze
·
Efudex
·
Carac
·
Picato
·
Actikerell
·
Fluoroplex
·
Ameluz
·
Metvixia
·
Levulan Kerastick
·
Alacare
·
Klisyri (tirbanibulin)
·
And Many Others
Request for Free
Sample Report: https://www.delveinsight.com/sample-request/actinic-keratosis-market
View Report: https://www.delveinsight.com/report-store/actinic-keratosis-market
Table of Contents:
1. Key Insights
2. Executive Summary
of Actinic Keratosis
3. Competitive
Intelligence Analysis for Actinic Keratosis
4. Actinic Keratosis
: Market Overview at a Glance
5. Actinic Keratosis
: Disease Background and Overview
6. Patient Journey
7. Actinic Keratosis
Epidemiology and Patient Population
8. Treatment
Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of
Actinic Keratosis Treatment
11. Marketed
Products
12. Emerging
Therapies
13. Actinic
Keratosis : Seven Major Market Analysis
14. Attribute
analysis
15. 7MM: Market
Outlook
16. Access and
Reimbursement Overview of Actinic Keratosis
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight
Capabilities
22. Disclaimer
Request for Free
Sample Report: https://www.delveinsight.com/sample-request/actinic-keratosis-market
About DelveInsight
DelveInsight is a leading Business Consultant, and Market
Research firm focused exclusively on life sciences. It supports Pharma
companies by providing end to end comprehensive solutions to improve their
performance. Get hassle-free access to all the healthcare and pharma
market research reports through our subscription-based platform PharmDelve.
View Report: https://www.delveinsight.com/report-store/actinic-keratosis-market
Comments
Post a Comment